The CCNI2 Polyclonal Antibody (PACO08254) is a valuable tool for researchers studying CCNI2, a protein involved in cell cycle progression and regulation. This antibody, produced in rabbits, exhibits high reactivity with human samples and has been validated for use in Western blot applications. By specifically binding to the CCNI2 protein, this antibody enables accurate detection and analysis in various cell types, making it ideal for research in cell biology and cancer studies.
CCNI2 is known for its role in promoting cell proliferation and survival, making it a key player in tumorigenesis and cancer development. By targeting CCNI2, researchers can gain insights into the mechanisms underlying cell cycle dysregulation and potential therapeutic targets for cancer treatment. Studying the function of CCNI2 is essential for advancing our understanding of cancer biology and developing novel strategies for cancer therapy.
